Back to News
Market Impact: 0.25
Modular Medical's Pivot Insulin Patch Pump Gets FDA Clearance For Software Enhancements
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationCompany FundamentalsProduct Launches
Modular Medical (MODD) said the FDA cleared software enhancements to its Pivot tubeless insulin patch pump. The clearance is a positive regulatory milestone for the company’s insulin delivery platform, though the news does not quantify revenue impact or changes to guidance.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
MODD0.55
More News
- Indonesian stocks plunge to six-year low as MSCI downgrade fears mount
- China's CXMT sees shares drop over 6% as investors look past chipmaker's profit turnaround
- Australia’s Cleanaway agrees to $6.5 bln EQT buyout bid; shares surge
- India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance
- Zoom and big financial firms add ‘Proof of Human’ badges from Sam Altman’s World to stop fraud and deep fakes
- Daiichi Life Offers to Buy Remainder of Australia’s Challenger